Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Insurance · ·
290.90 ₪
▲ 0.00 ₪ (+0.0%)
Market data updated: 09/19 09:31 AM
News analyzed: 09/19/2026
Market Cap
Not available
Day Range
288.20 ₪ - 297.00 ₪
52-Week Range
147.00 ₪ - 299.00 ₪
Beta
—
Next Earnings
—
Support
219.00 ₪
Resistance
297.00 ₪
+97.2% (1Y)
🟡 Moderate
Strengths: 10/13 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟢 Bullish
Technical Trend
🟢 Bullish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Calmar Ratio (return vs. drawdown)
Calmar: 2.74 (3y annualized return 70.6% / max drawdown 25.8%)
Risk
Biggest negative driver
RSI
RSI 78.3 — approaching overbought territory
Technical
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 0 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 0
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
CLIS.TA receives an overall Investor Score of 78, placing it in the STRONG rating category. This evaluation is heavily anchored by a high technical category score of 93, reflecting robust upward momentum across several key technical indicators. The stock's price currently trades above both its 50-day and 200-day simple moving averages, and the 50-day SMA recently crossed above the 200-day SMA in a bullish crossover signal. Furthermore, the MACD histogram remains positive, confirming rising momentum in the price action. Contrasting these trend strengths are short-term overbought conditions. The Relative Strength Index (RSI) stands at 83.3, while the Stochastic %K indicator has reached 99.0, signaling that recent gains have pushed momentum indicators into extended territory. The risk profile for CLIS.TA scores 58. The company exhibits a solid historical risk-adjusted return profile, evidenced by a 3-year annualized return of 72.2% against a maximum drawdown of 25.8%, resulting in a Calmar ratio of 2.80. The Average True Range (ATR) represents 2.8% of the stock's price, reflecting moderate trading volatility. Meanwhile, the news category reflects a neutral baseline score of 50 due to an absence of logged news events. Overall, the stock's high rating is supported primarily by technical trend alignment and historical performance metrics.
The technical score is 93, supported by price trading above the 50-day and 200-day moving averages, a recent SMA 50 cross above the SMA 200, and a positive MACD histogram. However, the RSI sits high at 83.3.
Strong moving average alignment and positive momentum indicate a robust uptrend, though high RSI values suggest short-term overbought conditions.
The news score is at a neutral 50 with no specific news evidence recorded in the dataset.
A neutral score indicates that technical price trends are currently developing without measured news sentiment drivers.
The risk category scores 58, featuring an ATR of 2.8% of price and a 3-year Calmar ratio of 2.80 based on a 72.2% annualized return and a 25.8% maximum drawdown.
Evaluating annualized returns against historical maximum drawdowns helps quantify risk-adjusted performance over longer timeframes.
StockIQ conclusion
CLIS.TA earns an overall Investor Score of 78 (STRONG), driven primarily by a technical score of 93. Key technical catalysts include price positioning above the 50-day and 200-day moving averages, a recent SMA golden cross, and a positive MACD histogram. While historical risk metrics remain supported by a 2.80 Calmar ratio, short-term momentum indicators like an RSI of 83.3 and %K of 99.0 highlight overbought conditions.
Written automatically from the computed data shown on this page only — not investment advice.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
71
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
No data available
Quality
No data available
Value
No data available
Momentum
82
Risk
58
Sentiment
50
Fundamental
No data available
Institutional
No data available
Stocks with a similar DNA right now
Not enough comparably-scored stocks yet to show similar matches.
SCANNING CLIS.TA...
🌡️ Emotional Temperature
42
🎯 Conviction (vs. Emotion)
50
Psychology
58
Fundamentals
—
Technical
82
Valuation
—
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
Extreme momentum, price far above its moving average, and a large premium over fair value.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Price (3M)
+28%
Market Narrative
58
Fundamental Reality
50
Narrative Gap
+8
🔀 Weak-Conviction Rally
Price is moving, but not accompanied by a matching rise in news attention/sentiment.
🧠 StockIQ Psychologist
The market behavior here is dominated by anchoring, with traders fixating on a tight resistance level (0.2% away), despite strong momentum and speculative euphoria (Euphoria score: 41). The FOMO-driven chase (+16.9% ROC, 1.21x volume) and overbought RSI (83) imply traders may overlook technical resistance, but the narrative-reality gap (14) hints at potential misalignment. The key question: will traders break through resistance or retreat to test it again? The absence of panic selling (score: 4) suggests no immediate liquidation pressure, but anchoring could cap upside until this level shifts.
Updated: 09/08/2026, 04:23 PM
What could change this?
📈 11D Investor Psychology
Signal classification confidence: Medium (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Jesse Livermore — 79/100
🔴 Weakest match
Samuel Armstrong Nelson — 2/100
🗣️ Why do they disagree?
Jesse Livermore’s high score (84) stands out as a clear outlier, signaling a strong bullish alignment with the stock’s price action—likely due to its momentum or trend-following characteristics. Meanwhile, methodologies like Howard Marks (66) and Gerald Loeb (54) offer cautious optimism, framing the risk as manageable but not negligible, with Marks noting no obvious cycle-timing red flags while Loeb acknowledges moderate capital risk. The middle ground is crowded with neutral or ambiguous verdicts (50s), where investors like Jack Schwager see no clear edge, while behavioral economists (Charles Mackay) and efficiency proponents (Malkiel/Bogle) either detect speculative crowd behavior or dismiss the stock’s alpha potential. At the extreme low end, Samuel Nelson’s near-zero score (1) flags an overbought cycle, contrasting sharply with Livermore’s enthusiasm. The divergence underscores how some frameworks prioritize technical momentum (Livermore) while others stress valuation gaps (Nelson) or market efficiency (Malkiel/Bogle), leaving little consensus beyond cautious optimism.
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟢 79
Positive trend — the price action Livermore looked for
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟢 71
Not enough dividend/growth data for a real Smith read
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
⚠️ Partial data for this stock — score is less reliable — Data availability: 25%
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 62
Mixed — a good business, but expectations may already be high
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 54
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 50
Not enough balance-sheet/valuation data for a real Graham read
Key question
Where is my margin of safety?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟡 50
Not enough fundamentals data for a real Fisher read
Key question
How exceptional is this business, really?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Peter Lynch
One Up on Wall Street (1989)
🟡 50
Not enough growth data for a real Lynch read
Key question
Is the growth worth the price?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟡 50
Some signs of crowd excitement building
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟡 50
Not enough balance-sheet data for a real Bagehot read
Key question
Does this company have enough liquidity to survive real stress?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 50
Not enough growth/insider data for a real Veblen read
Key question
Is management building real value, or just building itself?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟡 50
Not enough valuation data for a real Enterprising-Graham read
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 50
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 49
No clear edge either way
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 41
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟡 39
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
⚠️ Partial data for this stock — score is less reliable — Data availability: 30%
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🔴 2
Cycle looks stretched toward overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Based on the last 254 trading days, calculated from real price data. Click an indicator for details and a chart.
🟢 Most indicators support an uptrend (9 bullish · 2 bearish · 0 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear uptrend with no defined trading range in the period examined.
High confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 14.4.2026 | 495.233 ₪ |
| 13.4.2026 | 495.233 ₪ |
| 15.6.2025 | 251.280 ₪ |
| 14.6.2025 | 251.280 ₪ |
| 11.12.2024 | 125.940 ₪ |
| 10.12.2024 | 125.940 ₪ |
Sentiment based on basic keywords (not AI) — 0 positive, 0 neutral, 0 negative out of the last 0 articles.
No recent articles found for this stock.
StockIQ doesn't currently have enough real data to compute a reliable score for Clal Insurance Enterprises Holdings Ltd (CLIS.TA) — only 3 of 7 categories are available right now. Rather than show a misleading number, this page shows which data is missing instead.
StockIQ doesn't give buy/sell recommendations — and for CLIS.TA specifically, there currently isn't enough real data (only 3 of 7 categories available) to state even a factual score reliably. Check back once more data is available.
CLIS.TA's technical score is 82/100, which currently reads as bullish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Calmar: 2.74 (3y annualized return 70.6% / max drawdown 25.8%); Price is above the 50-day average; Price is above the 200-day average.
Based on the real signals StockIQ computed: RSI 78.3 — approaching overbought territory; %K 84.4 — overbought.
Yes — CLIS.TA has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Full breakdown of every data type and its source: Data Sources · Methodology